High-Throughput Screening System for Identification of Novel Drugs and Drug Targets
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 63/219,665, filed Jul 8, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,038,431 | High-Throughput Screening System for Identification of Novel Drugs and Drug Targets In force · High confidence | Medic Life Sciences Inc. | In force | High confidence | ||
| US 11,802,866 | High-Throughput Screening System for Identification of Novel Drugs and Drug Targets In force · High confidence | Medic Life Sciences, Inc. | In force | High confidence | ||
| Application 19/017,643 | High-Throughput Screening System for Identification of Novel Drugs and Drug Targets Pending Not granted | Medic Life Sciences Inc. | Pending | Not granted | ||
| Application 18/680,818 | High-Throughput Screening System for Identification of Novel Drugs and Drug Targets Abandoned Abandoned Jan 14, 2025 | Medic Life Sciences Inc. | Abandoned | Abandoned Jan 14, 2025 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Medic Life Sciences, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.